The Head of the Medical Supply Organisation’s (MSO) Management Committee has adopted the "Guidelines for Combating Waste in Medical Supplies, Pharmaceuticals, and Medical Equipment – First Edition (2026)."
It said this move comes as part of its efforts to enhance the efficiency of the medical supply system, safeguard public resources, and minimize loss and waste.
The MSO said the guidelines aim to establish a unified approach to managing requirements, inventory, expiration dates, storage, and distribution. The initiative seeks to reduce the expiration of pharmaceuticals and medical supplies and minimize instances of stagnant stock and spoilage, while also activating mechanisms for redistributing surpluses and implementing early warning systems for items at risk of waste.
The guidelines were developed based on principles of Good Storage and Distribution Practices (GSDP), inventory management and tracking systems, and medical product safety requirements. They have been adapted to suit the specific nature of Libya’s health supply system—accounting for multiple storage and distribution tiers, varying regional needs, and challenges related to funding, procurement, transportation, and emergency conditions.
The document emphasizes the importance of treating the medical supply chain as an integrated system—spanning from needs assessment and procurement, through storage, transport, and distribution, to final use and safe disposal—thereby mitigating risks and sources of waste at every stage of the supply chain.
The MSO said the issuance of this guide aligns with its efforts to establish a more efficient and sustainable national medical supply system, enhance pharmaceutical security in Libya, and safeguard public resources while ensuring their optimal utilization.
MSO issues Libyan National Formulary (LNF)
It will be recalled that in August this year, and for the first time in Libya, the MSO launched the Libyan National Formulary (LNF) - a unified national reference for medications - from selection to use, and from supply to patient safety.
For importers and exporters, this affects which medicines, brands and from which countries, are imported - and which are not.
Libya Launches First National Formulary to Reform Drug Supply
Libya’s Medical Supply Organisation Launches Digital Supply Platform
Libya Customs Authority to Launch Dedicated Medical Customs Facility
Libyan Medical Supply Organisation Financial Officer Detained Over Misuse of Funds
Libya PM Aldabaiba Orders Healthcare Supply Chain Reform and Digitization
Libya Launches Digitalization of Medical Supply Organisation Data